Zobrazeno 1 - 10
of 46
pro vyhledávání: '"G. J. Durant"'
Publikováno v:
Agents and Actions. 43:132-138
Publikováno v:
Agents and Actions. 43:139-143
Autor:
David J. Watkin, Keith Prout, G. J. Durant, D. G. Cooper, Ch R Ganellin, K. Burns, G. S. Sach
Publikováno v:
Acta Crystallographica Section B Structural Science. 49:547-559
The crystal and molecular structures of the following compounds showing histamine H2-antagonist activity have been determined: (1) N-Cyano-N'-methyl-N"-12[(2-pyridyl)methylthi_'o]ethyl } guanidine, C 11H 15 N5 S, Mr = 249.33, triclinic, P1, a = 7.482
Autor:
Y. G. J. Durant, Jean Guillot
Publikováno v:
Colloid & Polymer Science. 271:607-615
In seeded emulsion polymerization, during the second stage, new interfaces appear and the surface area changes. A thermodynamic equilibrium approach is presented which predicts particle morphology of a whole range of non-spherical particles upon poly
Publikováno v:
ChemInform. 24
5-(1,3-Benzodioxol-5-ylmethyl)-2-[2-(5-methyl-1H-imidazol-4-ylmethylthio)ethylamino]-4(1H)-pyrimidone dihydrochloride C 19 H 23 N 5 O 3 S 2+ .2Cl - , M r =472.4, triclinic, P1l, a=8.291 (2), b=10.759 (3), c=13.169 (3) A, α=108.42 (2), β=93.28 (2),
Publikováno v:
Acta Crystallographica Section C Crystal Structure Communications. 49:44-46
5-(1,3-Benzodioxol-5-ylmethyl)-2-[2-(5-methyl-1H-imidazol-4-ylmethylthio)ethylamino]-4(1H)-pyrimidone dihydrochloride C 19 H 23 N 5 O 3 S 2+ .2Cl - , M r =472.4, triclinic, P1l, a=8.291 (2), b=10.759 (3), c=13.169 (3) A, α=108.42 (2), β=93.28 (2),
Autor:
G. J. Durant, R W Brimblecombe, J W Black, Michael E. Parsons, Charon R. Ganellin, W. A. M. Duncan
Publikováno v:
British Journal of Pharmacology. 160:S52-S53
Burimamide and metiamide which have been described previously (Black, Duncan, Durant, Ganellin & Parsons, 1972; Black, Duncan, Emmett, Ganellin, Hesselbo, Parsons & Wyllie, 1973) are histamine H2-receptor antagonists. This communication describes som
Autor:
C E, Tedford, S L, Yates, G P, Pawlowski, J W, Nalwalk, L B, Hough, M A, Khan, J G, Phillips, G J, Durant, R C, Frederickson
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 275(2)
GT-2016, a non-thiourea-containing imidazole, has been developed as a histamine H3 antagonist. In vitro and in vivo studies in rats were conducted to characterize receptor selectivity and autoreceptor functionality for GT-2016. GT-2016 demonstrated h
Publikováno v:
Agents and actions. 43(3-4)
Publikováno v:
Agents and actions. 43(3-4)